Fused pyridines as kinase inhibitors
Abstract:
The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.
Public/Granted literature
Information query
Patent Agency Ranking
0/0